76 results
424B3
DMAC
DiaMedica Therapeutics Inc.
18 Jul 24
Prospectus supplement
5:28pm
coverage and adequate reimbursement for, our DM199 product candidate for AIS and PE both in the United States and internationally;
our ability to partner
8-K
EX-10.1
DMAC
DiaMedica Therapeutics Inc.
26 Jun 24
DiaMedica Therapeutics Announces $11.8 Million
8:16am
) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee
8-K
EX-10.1
jkce dks6
5 Sep 23
Departure of Directors or Certain Officers
4:15pm
424B3
oz2 hb7jnz
10 Jul 23
Prospectus supplement
4:16pm
8-K
EX-10.1
y40gad cgok2
21 Jun 23
DiaMedica Therapeutics Announces $37.5 Million Private Placement
8:42am
8-K
240qlrdau03 ba46y7
30 May 23
DiaMedica Therapeutics Announces Appointment of Dr. Richard Kuntz to the Board of Directors
8:30am
8-K
EX-3.1
uj3o5i3l2vd
18 May 23
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-10.2
me0s5cq6fkpwk
25 May 22
Departure of Directors or Certain Officers
4:49pm